TITLE

Is dexmedetomidine really superior to propofol?

AUTHOR(S)
Banik, Sujoy; Prabhakar, Hemanshu
PUB. DATE
October 2015
SOURCE
Journal of Anesthesia;Oct2015, Vol. 29 Issue 5, p813
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "A comparative study of dexmedetomidine and propofol as sole sedative agents for patients with aneurysmal subarachnoid hemorrhage undergoing diagnostic cerebral angiography," by K. Sriganesh and colleagues in the 2014 issue.
ACCESSION #
110340301

 

Related Articles

  • In reply: is dexmedetomidine really superior to propofol? Sriganesh, Kamath; Reddy, Madhusudan; Umamaheswara Rao, G. // Journal of Anesthesia;Oct2015, Vol. 29 Issue 5, p814 

    A response from the authors of the article "A comparative study of dexmedetomidine and propofol as sole sedative agents for patients with aneurysmal subarachnoid hemorrhage undergoing diagnostic cerebral angiography" in the 2014 issue is presented.

  • Meta-Analysis of the Effectiveness and Safety of Prophylactic Use of Nimodipine in Patients with an Aneurysmal Subarachnoid Haemorrhage. Guang Jian Liu; Jie Luo; Li Ping Zhang; Zheng Jun Wang; Li Li Xu; Guo Hou He; Yan Jun Zeng; Yun Fu Wang // CNS & Neurological Disorders - Drug Targets;Nov2011, Vol. 10 Issue 7, p834 

    Background and objectives: Cerebral vasospasm is an important cause of poor outcomes in subarachnoid haemorrhage patients. This study was designed to assess the effectiveness and safety of nimodipine in the prevention of cerebral vasospasm in aneurysmal subarachnoid haemorrhage patients....

  • Reversal of transcranial Doppler vasospasm with sildenafil. MacDonald, R. Loch // Surgical Neurology International;2012, Vol. 3 Issue 1, p20 

    The author reflects on the effectiveness of sildenafil in treating transcranial Doppler (TCD) vasospasm. He examines the study conducted by Mukherjee and colleagues which was participated by 72 patients with aneurysmal subarachnoid hemorrhage (SAH) and were treated with sildenafil when they...

  • Warning leak in subarachnoid hemorrhage. Ostergaard, John R. // BMJ: British Medical Journal (International Edition);7/28/90, Vol. 301 Issue 6745, p190 

    Examines the diagnosis of aneurysmal subarachnoid hemorrhage. Symptoms of the disease; Clinical feature of the disease; Efficacy of the treatment for cerebral aneurysms.

  • Laser-based treatment could benefit stroke victims. Chamberlain, Gary // Design News;3/3/97, Vol. 53 Issue 5, p15 

    Reports on efforts to better understand a new laser-based therapy for the victims of subarachnoid hemorrhages. Collaborative research by Sandia National Laboratories and Wellman Laboratories of Photomedicine; Current treatments; New procedure called pulsed laser hydraulic vasodilation;...

  • Treatment of Patients with High-Grade Aneurysmal Subarachnoid Hemorrhage. Redekop, Gary // Canadian Journal of Neurological Sciences;Jan2011, Vol. 38 Issue 1, p3 

    The author reflects on the report of R. J. Diaz and J. H. Wong on the selective approach in treating patients with high-grade aneurysmal subarachnoid hemorrhage (SAH). He is critical on the therapeutic problem faced by physicians who treat patients with high-grade aneurysmal SAH. An overview of...

  • Nymalize Oral Solution for Hemorrhage.  // Monthly Prescribing Reference;Jun2013, Vol. 29 Issue 6, pA30 

    The article informs that the nymalize oral solution has been approved for the treatment of patients experiencing symptoms resulting from a subarachnoid hemorrhage.

  • Subarachnoid Haemorrhage: Epidemiology, Risk Factors, and Treatment Options. Kaptain, G.J.; Lanzino, G.; Kassell, N.F. // Drugs & Aging;2000, Vol. 17 Issue 3, p183 

    The present review focuses on subarachnoid haemorrhage (SAH) secondary to the rupture of an intracranial aneurysm, a condition with a high case fatality rate. Additionally, many of the surviving patients are left with significant disabilities. Risk factors for aneurysmal SAH include both genetic...

  • Stroke: Specialized care by experienced teams cuts death and disability from bleeding brain aneurysms.  // Biomedical Market Newsletter;5/25/2012, Vol. 21, p1 

    The article informs that a neurosurgeon from the University of Michigan has published the guidelines for the treatment of subarachnoid hemorrhage.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics